Canopy

Canopy's Lavi Kwiatkowsky, Founder & CEO, and Michael Kolodziej, MD, Chief Medical Officer, are among the 2024 AVBCC Co-Chairs and will take part in several panels during this year's program. We hope to see you during this industry-leading event on value-based cancer care! Learn more: https://lnkd.in/ehnFn2we

ICYMI! Canopy recently announced platform-wide support for bispecific antibodies: https://lnkd.in/e-ri3jWT “Patients receiving these treatments require vigilant monitoring and nuanced management to ensure safety. Canopy’s technology plays a crucial role in keeping patients safe when they’re away from the clinic, especially when administering bispecific antibodies and CAR-T in the outpatient setting.” —James Essell, MD, Medical Director of the Center for Cancer and Cellular Therapy at Oncology Hematology Care and The Jewish Hospital, and Chair for Cellular Therapy at Sarah Cannon Research Institute Canopy's Continuous Care Platform supports care teams in safely administering these therapies in the outpatient setting through ePRO-based remote monitoring, smart triage algorithms, and decision-support pathways for CRS and ICANs. Read our official press release to learn more: https://lnkd.in/e-ri3jWT

What an incredible week at the ONCare Leadership Summit! Canopy was honored to sponsor, and our Chief Medical Officer, Michael Kolodziej, MD, took part in three insightful panels: • When the 800 lb. Gorilla Comes Knocking: Hospital-Practice Affiliation Basics • Negotiating With & Managing Hospital Relationships • Understanding Payers: A Primer Thank you to ONCare Alliance for a stellar event and for all you do to ensure people with cancer achieve the best possible outcomes. Curious how Canopy helps care teams deliver continuous care? Learn more here: www.canopycare.us

Thank you to IT Digest for featuring our launch of platform-wide support for bispecific antibodies. Read below to learn how Canopy helps oncology practices safely integrate these novel therapies into the outpatient setting.

Attending ONCare Leadership Summit? Be sure to stop by the Canopy booth to meet our team and join Michael Kolodziej, MD, Canopy's Chief Medical Officer, as he participates in the following panels: • When the 800 lb. Gorilla Comes Knocking: Hospital-Practice Affiliation Basics • Negotiating With & Managing Hospital Relationships • Understanding Payers: A Primer Learn more about Canopy's approach to continuous care and find time to meet here: www.canopycare.us ONCare Alliance

📣 Announced Today! 📣 We’re excited to launch platform-wide support for bispecific antibodies, including ePRO-based remote monitoring, smart triage algorithms, and decision-support pathways for CRS and ICANs. “Patients receiving these treatments require vigilant monitoring and nuanced management to ensure safety. Canopy’s technology plays a crucial role in keeping patients safe when they’re away from the clinic, especially when administering bispecific antibodies and CAR-T in the outpatient setting.” —James Essell, MD, Medical Director of the Center for Cancer and Cellular Therapy at Oncology Hematology Care and The Jewish Hospital, and Chair for Cellular Therapy at Sarah Cannon Research Institute Read our official press release to learn more: https://lnkd.in/e-ri3jWT

We're counting down to the ONCare Leadership Summit! Be sure to stop by the Canopy booth and join Dr. Michael Kolodziej, MD, Canopy's Chief Medical Officer, as he participates in the following panels: • When the 800 lb. Gorilla Comes Knocking: Hospital-Practice Affiliation Basics • Negotiating With & Managing Hospital Relationships • Understanding Payers: A Primer Learn more about Canopy's approach to continuous care and find time to meet here: www.canopycare.us ONCare Alliance

#PCOC2024 is here! Canopy is a proud sponsor of this year's program, and our team is excited to connect. Learn more about how Canopy supports oncology practices with continuous care management: www.canopycare.us AJMC - The American Journal of Managed Care

We're excited to see the Community Oncology Alliance (COA) introduce new Quality and Value Standards highlighting critical aspects of cancer care. At Canopy, we share COA's commitment in supporting practices as they deliver high-quality care: Canopy's Continuous Care Platform helps practices: 🔄 Extend access to care between visits via ePRO-based monitoring 📊 Enhance patient outcomes—our studies demonstrate a 22% reduction in ER visits and hospitalizations and up to a 45% increase in treatment persistence at 3 months (ASCO 2022) ⚙️ Streamline care coordination across teams with intelligent triage tools and pathways 🎯 Prepare for success in certification programs and value-based care models like the EOM Learn more: www.canopycare.us

We're reflecting on an incredible weekend at Clinical Pathways Congress + Cancer Care Business Exchange! Canopy's Lavi Kwiatkowsky, Michael Kolodziej, and Joshua Beauregard all took the stage alongside an all-star lineup of thought leaders. During the Innovation Showcase, Lavi and Josh demonstrated how continuous care management—proactively managing patients' symptoms between visits—is becoming a cornerstone of value-based care. They shared: 📱Canopy's real-world evidence on how continuous care models and ePROs are enhancing outcomes for people with cancer ⚙️ Challenges that make continuous care difficult for hardworking care teams and practice leaders 💡 How Canopy helps practices keep care management in-house by streamlining operations and capturing reimbursement for this quality care Thank you to the team at Clinical Pathways Congress + Cancer Care Business Exchange for this opportunity and to all of our partners in community oncology for your commitment to providing the best possible outcomes for people with cancer. To learn more about Canopy and our approach to continuous care management, visit www.canopycare.us